Cresco Labs (CRLBF) Inventory Average (2021 - 2026)
Cresco Labs (CRLBF) posted Inventory Average of $103.6 million for Q1 2026, up 8.17% on a QoQ basis from $95.7 million in Q4 2025, and up 21.67% year-over-year from $85.1 million in Q1 2025.
Cresco Labs (CRLBF) Inventory Average (2021 - 2026) Analysis & Trends
Cresco Labs' Inventory Average history runs 6 years deep, the most recent figure standing at $103.6 million for Q1 2026.
- Quarterly Inventory Average rose 21.67% year-over-year to $103.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $103.6 million (up 21.67% YoY) and the FY2025 annual result came in at $91.0 million, down 4.77% from the prior year.
- Inventory Average was $103.6 million for Q1 2026 at Cresco Labs, up from $95.7 million in the prior quarter.
- Across five years, Inventory Average topped out at $157.7 million in Q2 2022 and bottomed at $85.1 million in Q1 2025.
- A 5-year average of $114.1 million and a median of $103.6 million in 2026 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2022 — Inventory Average jumped 105.65% — and 2023, when it declined 24.4%.
- Cresco Labs' Inventory Average stood at $143.6 million in 2022, then decreased by 22.55% to $111.2 million in 2023, then slipped by 21.06% to $87.8 million in 2024, then climbed by 9.05% to $95.7 million in 2025, then rose by 8.17% to $103.6 million in 2026.
- Business Quant data shows CRLBF's Inventory Average at $103.6 million in Q1 2026, $95.7 million in Q4 2025, and $91.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 180.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.11 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.73 Bn |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | 103.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 103.55 Mn |
| Dec 31, 2025 | 95.74 Mn |
| Sep 30, 2025 | 90.99 Mn |
| Jun 30, 2025 | 88.03 Mn |
| Mar 31, 2025 | 85.11 Mn |
| Dec 31, 2024 | 87.79 Mn |
| Sep 30, 2024 | 93.69 Mn |
| Jun 30, 2024 | 96.77 Mn |
| Mar 31, 2024 | 103.09 Mn |
| Dec 31, 2023 | 111.22 Mn |
| Sep 30, 2023 | 117.75 Mn |
| Jun 30, 2023 | 127.87 Mn |
| Mar 31, 2023 | 134.74 Mn |
| Dec 31, 2022 | 143.60 Mn |
| Sep 30, 2022 | 155.75 Mn |
| Jun 30, 2022 | 157.67 Mn |
| Mar 31, 2022 | 146.54 Mn |
| Dec 31, 2021 | 134.09 Mn |
| Mar 31, 2021 | 71.26 Mn |